Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)

Details for Australian Patent Application No. 2010323037 (hide)

Owner Biotest AG

Inventors Osterroth, Frank; Uherek, Christoph; Bruecher, Christoph; Rottgen, Peter; Daelken, Benjamin; Engling, Andre; Zuber, Chantal; Czeloth, Niklas

Agent Davies Collison Cave

Pub. Number AU-A-2010323037

PCT Pub. Number WO2011/064399

Priority 0920933.9 30.11.09 GB; 0920940.4 30.11.09 GB; 0920942.0 30.11.09 GB

Filing date 30 November 2010

Wipo publication date 3 June 2011

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/064399 Priority application(s): WO2011/064399

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010323042-Novel 7beta-hydroxysteroid dehydrogenases and their use

2010323036-Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)